A high-performance anion exchange resin performs well compared with membranes. In addition, the resin offers greater flexibility and cost savings.
Despite different material, agitation, and aeration, the performance of the disposable bioreactor is similar to that of stainless steel bioreactors.
Traditional project decision-making vs. a QbD approach.
Despite different material, agitation, and aeration, the performance of the disposable bioreactor is similar to that of stainless steel bioreactors.
Newer classes of biotherapies will require innovations in processing technology.
The author describes recent developments to help overcome the downstream-processing bottleneck.
Establishing the CQAs of a mAb product by evaluating impact and uncertainty during risk assessment.
Cell concentrations and resulting protein concentrations are higher in a concentrated fed-batch process than in a standard fed-batch culture system.
The authors re-examine environmental controls in the context of technical advances in manufacturing.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The authors review efforts to limit polymer degradation without significantly impeding cell growth.
The author presents opportunities and challenges in implementing the product lifecycle approach.
The author discusses the various ways in which a quality-by-design program can enhance the extractable and leachable assessment of a drug product.
The use of commercially available media to achieve high titer in early process development is discussed.
The use of commercially available media to achieve high titer in early process development is discussed.
The use of commercially available media to achieve high titer in early process development is discussed.
The use of commercially available media to achieve high titer in early process development is discussed.
Switching to single-use bioreactors can have financial and performance benefits.